Recurrent melioidosis in the Darwin Prospective Melioidosis Study: improving therapies mean that relapse cases are now rare

Derek Sarovich, Linda Ward, Erin Price, Mark Mayo, Matthew Pitman, Robert Baird, Bart Currie

    Research output: Contribution to journalArticle

    27 Citations (Scopus)

    Abstract

    The Darwin Prospective Melioidosis Study has documented 785 melioidosis cases over 23 years. Recurrent melioidosis occurred in 39/679 (5.7%) patients surviving initial infection; 29 patients suffered relapse of the original infection, and 10 presented with a new Burkholderia pseudomallei infection. With improved therapy, relapse has become rare in recent years.

    Original languageEnglish
    Pages (from-to)650-653
    Number of pages4
    JournalJournal of Clinical Microbiology
    Volume52
    Issue number2
    DOIs
    Publication statusPublished - 2014

    Fingerprint Dive into the research topics of 'Recurrent melioidosis in the Darwin Prospective Melioidosis Study: improving therapies mean that relapse cases are now rare'. Together they form a unique fingerprint.

  • Cite this